动脉粥样硬化型急性缺血性脑卒中血管内治疗研究进展  

Recent advance in endovascular therapy for acute ischemic stroke due to intracranial atherosclerotic stenosis

作　　者：王禹 张建刚[2] 李振华[2] 杨清成[2] Wang Yu;Zhang Jiangang;Li Zhenhua;Yang Qingcheng(Graduate School,Xinxiang Medical University,Xinxiang 453000,China;department of Neurology,People's Hospital of Anyang City,Anyang 455000,China)

机构地区：[1]新乡医学院研究生院,新乡453000 [2]安阳市人民医院神经内科,455000

出　　处：《中华神经医学杂志》2020年第7期729-734,共6页Chinese Journal of Neuromedicine

摘　　要：颅内动脉粥样硬化(ICAS)是急性缺血性脑卒中(AIS)的主要病因之一。目前主流的静脉溶栓治疗虽然具有较好的疗效,但再通率低、血管再闭塞风险较高。近年来,血管内治疗因其时间窗长、再通率高及并发症少的优点得以快速发展。本文围绕ICAS型AIS的发病机制、主要治疗方法、挽救措施及并发症进行综述,重点阐述血管内治疗的发展进程。Intracranial atherosclerosis(ICAS)is one of the main pathogenesis of acute ischemic stroke(AIS).Intravenous thrombolysis is a main therapeutic method,enjoying good effect,but the recanalization rate is low and the risk of re-occlusion is high.Endovascular therapy has developed rapidly in recent years due to its long time-window for treatment,high recanalization rate and few complications.This article reviews the pathogenesis,characteristics,main therapeutic methods,complications and rescue measures of AIS due to ICAS.And the development of intravascular therapy is highlighted.

关 键 词：急性缺血性脑卒中 动脉粥样硬化 血管内治疗 

分 类 号：R743.3[医药卫生—神经病学与精神病学]